EBCC 7: Stem cells in breast cancer
Dr Clark discusses how cancer stem cells can be targeted by inhibiting the Notch signalling pathway. Dr Robert Clarke of the Paterson Institute for Cancer ...
ecancer
Highlights of the 10th European Cancer Conference (EBCC-10) by Dr Giuseppe Curigliano
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from ...
EMG-Health
Expert video report on triple negative breast cancer from ASCO 2020
Reporting remotely on findings presented at ASCO 2020 Virtual Meeting, Javier Cortes comments on study results in neoadjuvant triple negative breast cancer ...
European Society for Medical Oncology
EBCC 8: Debate on the success of breast cancer screening programmes
Link to full interview: http://ecancer.org/tv/conference/140/1312 Prof Richard Peto discusses the controversy behind screening for early stage breast cancer at the ...
ecancer
ESMO Breast Cancer 2020: Science, education, networking
Sibylle Loibl, ESMO Breast Cancer Co-Chair, shares her insights into the upcoming edition of the Congress and the reasons why it is a must-attend meeting for ...
European Society for Medical Oncology
How to use Neoadjuvant Therapies in Breast Cancer?
There are two main goals to perform neoadjuvant systemic therapy for women with breast cancer. The first goal is to obtain a pathological complete response ...
European Society for Medical Oncology
Advanced Breast Cancer - European Multidisciplinary Cancer Congress 2011
ESMO interviews Fabrice André, MD, PhD: an independent expert comment on the impact of the ph-III BOLERO-2 study and a perspective on clinical practice ...
European Society for Medical Oncology
Breast cancer and social issues: EBCC 2012 review
Prof Zielinski reports on data about the influence of obesity on breast cancer treatment outcome and calls for doctors to be ready to answer patient questions with ...
European Society for Medical Oncology
IMPAKT Breast cancer conference: how to move forward towards personalised medicine
Metastatic breast cancer: what hopes for what is called an orphan disease? Andrew Tutt and Peter Dubsky, IMPAKT 2013 co-chairs, highlight new approaches ...
European Society for Medical Oncology
Challenges posed by intratumor heterogeneity - IMPAKT 2012 Breast Cancer Conference
Prof. Swanton offers a clear-cut picture of the challenges and opportunities offered by improved knowledge of intratumor heterogeneity. ESMO reports from the ...
European Society for Medical Oncology
EBCC 7: Targeted therapy for breast cancer
Dr Jones discusses the use of Trastuzumab (Herceptin) and Lapatinib as drugs to target the HER2 receptor and the possibility of combining these as part of a ...
ecancer
How society and medical professionals should deal with breast cancer patients: EBCC 2012 review
Prof Zielinski reviews important discussions highlighting the need for a truly specialized multidisciplinary approach. ESMO reports from the European Breast ...
European Society for Medical Oncology
How to use endocrine therapy in premenopausal women with ER+ metastatic breast cancer
In this educational video of the 'How To' series, Fatima Cardoso explains how to treat premenopausal women with ER-positive, HER2-negative metastatic breast ...
European Society for Medical Oncology
Lobular Breast Cancer Event: An Evening of Learning
Lobular Breast Cancer Event: An Evening of Learning hosted by Cleveland Clinic partnered with the Lobular Breast Cancer Alliance (LBCA.) The program ...
Cleveland Clinic
ESMO Clinical Practice Guidelines: Breast cancer case presentation
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Fatima Cardoso, MD, ...
EMG-Health
Genetically determining susceptibility of breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the ...
EMG-Health
Breast cancer in Europe: Epidemiology and outcomes
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jan-Willem Coebergh, MD, PhD, from ...
EMG-Health
Why do we study the genetics of breast cancer?
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Prof Douglas Easton, Professor of ...
Patient Power Europe
1st European THINK TANK MEETING on Breast Cancer
Summarizing this new innovative concept of making meetings (Innovation Factory™ Institute Methodology and hosted) This event was held in Barcelona on Nov ...
Innovation Factory™ Institute
EBCC 7: Advances in breast cancer treatments
Technical advances can lead to benefits for women, for instance marking areas most at risk of relapse to allow targeted radiotherapy, and using a small number ...
ecancer
Milan Breast Cancer Conference 2009: Breast cancer prevention targets
Dr Karen Johnson - National Cancer Institute, USA, speaking at the 11th Milan Breast Cancer Conference: Increasing efficiency with small trials for breast cancer ...
ecancer
EBCC 7: The impact of breast reconstruction on patient quality of life
Dr Winters discusses the effects breast reconstruction can have on patients' quality of life and outlines the aims of the QUEST trial: introduced to assess the ...
ecancer
Possible strategies to attack triple negative breast cancer - IMPAKT 2012 Breast Cancer Conference
Dr Di Leo explains why triple negative breast cancer is a difficult heterogeneous disease and which are potential new promising approaches. ESMO reports from ...
European Society for Medical Oncology
Checkpoint inhibitors for triple-negative breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from ...
EMG-Health
Key Insights: Breast Cancer
Advancements in breast cancer care continue to rapidly evolve and the San Antonio Breast Cancer Symposium (SABCS) is the premier annual forum for ...
ImedexCME
IMPAKT 2016: Improving care and knowledge through translational research in breast cancer
Conference Scientific Chair, R. Coleman, interviews Conference Executive Chair, P. Bedard about some of the hot topics at IMPAKT 2016, a unique meeting ...
European Society for Medical Oncology
Chemotherapy Foundation Symposium 2012: Breast Cancer
This Best of the Day activity was filmed live at the Chemotherapy Foundation Symposium and features an interview with Dr. Harold Burstein, who provide a ...
ImedexCME
Management of inflammatory breast cancer
Prof Ghosn speaks with ecancer at the 10th BGICC in Cairo about diagnosis and treatment of inflammatory breast cancers in North Africa. He describes the ...
ecancer
Dr. Angel Rodriguez - Findings on Lapatinib's role in tackling cancer stem cells
Dr. Angel Rodriguez - Lester and Sue Smith Breast Centre, Baylor College of Medicine, Houston - Speaking at the 6th European Breast Cancer Conference ...
ecancer
Natalie Marshall | 2017 San Antonio Breast Cancer Symposium
Dr. Natalie Marshall discusses the length of hormonal blockade, hormone therapy for advanced disease, triple negative breast cancer, Her2 positive breast ...
Sutter Health
2nd European Lung Cancer Conference - Video Highlights Part.1
ESMO reports from ELCC 2010. http://www.esmo.org Importance of tobacco control in lung cancer. Video produced by the European Society for Medical ...
European Society for Medical Oncology
Guidelines and management of advanced breast cancer in limited resource settings
Prof El Saghir talks to ecancertv at SABCS 2015 about the development of resource-based guidelines for the management of advanced breast cancer in low- ...
ecancer
ESO-ESMO-ABC guidelines in metastatic breast cancer
Dr Saghir speaks with ecancer at the 10th BGICC in Cairo about updates to international guidelines for diagnosis, staging and treatment of advanced breast ...
ecancer
Triple Negative Breast Cancer: Medical Update
As someone diagnosed with triple-negative breast cancer, you may have specific concerns about treatment options, chemotherapy side effects and risk of ...
Living Beyond Breast Cancer
European Cancer Congress 2013: Lung Cancer
Imedex is pleased to present Best of the Day from the 38th Congress of the European Society of Medical Oncology (ESMO). This daily update is brought to you ...
ImedexCME
Breast cancer highlights from ASCO 2019
Dr Matteo Lambertini speaks with ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the conference highlights in breast ...
ecancer
Predicting late recurrence of breast cancer
At the 14th St. Gallen International Breast Cancer Conference 2015, Eleftherios P. Mamounas, MD, of University of Florida Health Cancer Center-Orlando Health ...
EMG-Health
2005–2015 global analysis of advanced breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the ...
EMG-Health
Medical Update: Hormone Receptor-Positive Metastatic Breast Cancer
Hormone receptor-positive metastatic breast cancers test positive for estrogen (ER-positive) or progesterone (PR-positive) receptors , or both, and often respond ...
Living Beyond Breast Cancer
ESMO 2019: Dr. O'Shaughnessy Highlights Progress in Breast Cancer
Joyce A. O'Shaughnessy, MD, the co-chair of Breast Cancer Research and chair of Breast Cancer Prevention Research at Baylor-Sammons Cancer Center and ...
OncLiveTV
San Antonio Breast Cancer Symposium: Updates on Medical Oncology and Survivorship
NYU Langone medical oncologist Dr. Marleen Meyers discusses updates on medical oncology and cancer survivorship at the annual San Antonio Breast ...
NYU Langone Health
Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1
Prof Fabrice André presents data at the ESMO 2018 congress in Munich from a phase III combination therapy trial including a targeted PI3K inhibitor to treat men ...
ecancer